| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $139.7M | +120.0% |
| R&D Expense | $409.6M | +11.4% |
| SG&A Expense | $113.8M | +2.1% |
| Operating Income | -$383.7M | +7.7% |
| Pre-tax Income | -$80.0M | +78.8% |
| Income Tax | $0 | -100.0% |
| Net Income | -$80.0M | +78.8% |
| EPS (Basic) | -$0.81 | +82.3% |
| EPS (Diluted) | -$0.81 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $294.9M | +4.6% |
| Short-term Investments | $950.3M | +67.1% |
| Current Assets | $1.27B | +44.5% |
| Total Assets | $1.48B | +34.2% |
| Current Liabilities | $96.9M | -46.8% |
| Total Liabilities | $242.8M | -34.4% |
| Stockholders' Equity | $1.24B | +68.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$345.1M | +0.6% |
| Capital Expenditures | $14.9M | +67.1% |
| Investing Cash Flow | -$121.4M | -165.6% |
| Financing Cash Flow | $478.0M | +6079.5% |
| Free Cash Flow | -$360.0M | -1.1% |
| +82.3% |